DAFNA Capital Management LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 2:35 pm Sale | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | DAFNA Capital Management LLC | 895,200 1.370% | -215,849 (-19.43%) | Filing |
| 2024-02-14 2:54 pm Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | DAFNA Capital Management LLC | 1,111,049 5.490% | 1,111,049 (New Position) | Filing |